GI Oncology
Conference Coverage
Bevacizumab Beyond Progression Extends Survival in Metastatic CRC
News
Lymphadenectomy Underused in GI Cancer Surgery
Major Finding: By 2009, the percentage of patients with adequate lymphadenectomy during surgery for gastrointestinal cancer was 43% for esophageal...